JP2011520991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520991A5 JP2011520991A5 JP2011510782A JP2011510782A JP2011520991A5 JP 2011520991 A5 JP2011520991 A5 JP 2011520991A5 JP 2011510782 A JP2011510782 A JP 2011510782A JP 2011510782 A JP2011510782 A JP 2011510782A JP 2011520991 A5 JP2011520991 A5 JP 2011520991A5
- Authority
- JP
- Japan
- Prior art keywords
- ethoxy
- compound
- pharmaceutical composition
- compound according
- pyridazinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 241000430519 Human rhinovirus sp. Species 0.000 claims 4
- 208000005155 Picornaviridae Infections Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- -1 6- {2- [1- (6-Methyl-3-pyridazinyl) -4-piperidinyl] ethoxy} -3-ethoxy-1,2-benzisoxazole bis-phosphate dihydrogen salt Chemical class 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- DKSVBVKHUICELN-UHFFFAOYSA-N 3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole Chemical compound C=1C=C2C(OCC)=NOC2=CC=1OCCC(CC1)CCN1C1=CC=C(C)N=N1 DKSVBVKHUICELN-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5634108P | 2008-05-27 | 2008-05-27 | |
| US61/056,341 | 2008-05-27 | ||
| PCT/AU2009/000663 WO2009143571A1 (en) | 2008-05-27 | 2009-05-27 | Antiviral salts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011520991A JP2011520991A (ja) | 2011-07-21 |
| JP2011520991A5 true JP2011520991A5 (enExample) | 2012-07-05 |
| JP5469662B2 JP5469662B2 (ja) | 2014-04-16 |
Family
ID=41376478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011510782A Expired - Fee Related JP5469662B2 (ja) | 2008-05-27 | 2009-05-27 | 抗ウイルス剤の塩 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8580791B2 (enExample) |
| EP (1) | EP2297141B1 (enExample) |
| JP (1) | JP5469662B2 (enExample) |
| KR (1) | KR20110019759A (enExample) |
| CN (1) | CN102046621B (enExample) |
| AU (1) | AU2009253738B2 (enExample) |
| BR (1) | BRPI0912038A2 (enExample) |
| CA (1) | CA2725618C (enExample) |
| CO (1) | CO6280534A2 (enExample) |
| EA (1) | EA020455B1 (enExample) |
| MX (1) | MX2010013019A (enExample) |
| NZ (1) | NZ590286A (enExample) |
| WO (1) | WO2009143571A1 (enExample) |
| ZA (1) | ZA201009284B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG184430A1 (en) | 2010-04-15 | 2012-11-29 | Biota Scient Management | Compound for treatment of respiratory condition or disease |
| EP2585067B1 (en) * | 2010-06-25 | 2017-08-09 | Biota Scientific Management Pty Ltd | Compound for the treatment of enteroviruses |
| CN102617462B (zh) * | 2012-02-28 | 2014-02-12 | 南京大学 | 特异性抑制肌肉微小核糖核酸的化合物及其合成方法和应用 |
| BR112016029942A2 (pt) * | 2014-06-20 | 2017-08-22 | Aviragen Therapeutics Inc | composto, forma de base livre cristalina anidra, composição farmacêutica, método para fabricação de uma forma de base livre cristalina, método de tratamento de uma infecção viral, método de tratar, aliviar, prevenir ou reduzir os sintomas ou exacerbações de asma ou doença pulmonar obstrutiva crônica e método de tratamento de doença mão, pé e boca |
| CA3216679A1 (en) * | 2021-05-05 | 2022-11-10 | George R. Painter | Nucleotide and nucleoside therapeutic compositions, combinations and uses related thereto |
| WO2024192151A2 (en) * | 2023-03-13 | 2024-09-19 | Altesa BioSciences, Inc. | Method of dosing vapendavir to treat enterovirus infections |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1170387B (it) | 1982-06-07 | 1987-06-03 | Glaxo Group Ltd | Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono |
| GB2162522B (en) | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
| GB9026998D0 (en) | 1990-12-12 | 1991-01-30 | Glaxo Group Ltd | Medicaments |
| US5514778A (en) * | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
| US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
| US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
| AU6031898A (en) * | 1997-01-22 | 1998-08-07 | Eli Lilly And Company | Anti-viral compounds |
| EP1001767A4 (en) * | 1997-06-04 | 2001-07-04 | Lilly Co Eli | ANTIVIRAL CONNECTIONS |
| US6358971B1 (en) * | 1998-05-20 | 2002-03-19 | Eli Lilly And Company | Anti-viral compounds |
| TR200003414T2 (tr) * | 1998-05-20 | 2001-03-21 | Eli Lilly And Company | Anti-viral terkipler |
| AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
-
2009
- 2009-05-27 NZ NZ590286A patent/NZ590286A/en not_active IP Right Cessation
- 2009-05-27 AU AU2009253738A patent/AU2009253738B2/en not_active Ceased
- 2009-05-27 JP JP2011510782A patent/JP5469662B2/ja not_active Expired - Fee Related
- 2009-05-27 EP EP09753335.0A patent/EP2297141B1/en not_active Not-in-force
- 2009-05-27 MX MX2010013019A patent/MX2010013019A/es active IP Right Grant
- 2009-05-27 WO PCT/AU2009/000663 patent/WO2009143571A1/en not_active Ceased
- 2009-05-27 EA EA201001835A patent/EA020455B1/ru not_active IP Right Cessation
- 2009-05-27 CN CN200980120191.2A patent/CN102046621B/zh not_active Expired - Fee Related
- 2009-05-27 BR BRPI0912038A patent/BRPI0912038A2/pt not_active IP Right Cessation
- 2009-05-27 US US12/994,633 patent/US8580791B2/en active Active
- 2009-05-27 KR KR1020107029303A patent/KR20110019759A/ko not_active Ceased
- 2009-05-27 CA CA2725618A patent/CA2725618C/en not_active Expired - Fee Related
-
2010
- 2010-11-25 CO CO10148308A patent/CO6280534A2/es not_active Application Discontinuation
- 2010-12-23 ZA ZA2010/09284A patent/ZA201009284B/en unknown
-
2013
- 2013-09-10 US US14/023,280 patent/US9206171B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520991A5 (enExample) | ||
| UA90545C2 (ru) | Твердая фармацевтическая лекарственная форма для перорального введения с быстрым высвобождением ингибитора фактора ха свертывания крови | |
| WO2007127635A3 (en) | Diketo-piperazine and piperidine derivatives as antiviral agents | |
| JP2013518107A5 (enExample) | ||
| NZ593712A (en) | Intermediates for synthesising nucleoside aryl phosphoramidates | |
| JP2008538115A5 (enExample) | ||
| JP2011507977A5 (enExample) | ||
| JP2010514807A5 (enExample) | ||
| EP2039686A4 (en) | DIHYDROPYRIMIDIN COMPOUNDS AND THEIR USES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PREVENTION OF ANTIVIRAL DISEASES | |
| JP2008528761A5 (enExample) | ||
| JP2009506014A5 (enExample) | ||
| JP2010518061A5 (enExample) | ||
| NZ596154A (en) | Cyclic compound having substituted phenyl group | |
| CN115315423A (zh) | 取代芳基类化合物 | |
| JP2011527687A5 (enExample) | ||
| NO20044571L (no) | Isokinolinderivater | |
| JP2010521516A5 (enExample) | ||
| JP2009534373A5 (enExample) | ||
| SG179031A1 (en) | Hsl inhibitors useful in the treatment of diabetes | |
| JP2012508256A5 (enExample) | ||
| JP2009513604A5 (enExample) | ||
| JP2010500284A5 (enExample) | ||
| JP2011519873A5 (enExample) | ||
| JP2009541455A5 (enExample) | ||
| JP2012504584A5 (enExample) |